Key facts
- Lyxia’s last known valuation is $57.0M (Sep 2014).
- It has raised $34.1M; the latest was Later Stage VC in Jan 2025.
- Notable investors include Oriental Fortune Capital, Decent Capital, Guofu Innovation, Fanqie Capital, Hatchip Capital — 12 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 12 names
- ·Watchlist + deal alerts for Lyxia
- ·The full record, as it builds
Funding rounds
No funding rounds for Lyxia are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Lyxia
Manufacturer of microalgae-derived nutritional ingredients intended for human and animal health through targeted lipid and bioactive compound development. The company offers vertically integrated cultivation, environmentally aligned production methods, and specialized extraction techniques that preserve the characteristics of sensitive components, enabling nutrition, health, and wellness industries to incorporate stable and traceable quality.
- Sector
- Materials and Resources
- HQ
- Huzhou, China
- Founded
- 2012
- Employees
- 130
- Website
- xiaozaotech.com/
- Ownership
- Privately Held (backing)
Lyxia doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Lyxia shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Lyxia in its N-PORT filings yet. We sweep new filings monthly.